Format

Send to

Choose Destination
Haematologica. 2019 Apr 19. pii: haematol.2019.222588. doi: 10.3324/haematol.2019.222588. [Epub ahead of print]

Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia.

Author information

1
Department of Internal Medicine III, Ulm University, Ulm, Germany.
2
Dept. Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin,Germany.
3
AbbVie, North Chicago, IL, USA.
4
Department of Internal Medicine III, Ulm University, Ulm, Germany; stephan.stilgenbauer@uniklinik-ulm.de.

KEYWORDS:

BCL2; Chronic Lymphocytic Leukemia; Cytogenetics and Molecular Genetics; Drug Resistance; Venetoclax

PMID:
31004028
DOI:
10.3324/haematol.2019.222588
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center